(Q24244547)

2

0 references

Yunxia Liu

3

0 references

Mao Ling Wei

4

0 references

Sameline Grimsgaard

Cochrane Database of Systematic Reviews

5

0 references

publication date

25 January 2006

0 references

published in

0 references

cites work

Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

A novel treatment for constipation-predominant irritable bowel syndrome using Padma Lax, a Tibetan herbal formula

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Risks associated with the practice of traditional Chinese medicine: an Australian study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Diagnosis and therapy of irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Chinese proprietary medicine in Singapore: regulatory control of toxic heavy metals and undeclared drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Meta-analysis: The treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Towards positive diagnosis of the irritable bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Liver enzyme elevations in patients treated with traditional Chinese medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Effects of cisapride on symptoms and postcibal small-bowel motor function in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

A systematic review of alternative therapies in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Irritable bowel syndrome: a little understood organic bowel disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

The management of irritable bowel syndrome: a European, primary and secondary care collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Probiotics for irritable bowel syndrome: a light in the darkness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Do certain countries produce only positive results? A systematic review of controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Recent advances: complementary medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Traditional Chinese medicine: an approach to scientific proof and clinical validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

The Clinical Course and Prognostic Determinants of the Irritable Bowel Syndrome: A Literature Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

Chinese herbal medicine for irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

7 January 2021

The treatment of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

7 January 2021

The symptomatic effect of cisapride in patients with irritable bowel syndrome and constipation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

7 January 2021

[Observation on intestinal flora in patients of irritable bowel syndrome after treatment of Chinese integrative medicine]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004116.PUB2

7 January 2021